To include your compound in the COVID-19 Resource Center, submit it here.

Iluvien regulatory update

Alimera resubmitted an NDA to FDA for Iluvien to treat diabetic macular edema. According to

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE